☆ 4.8 Article

A novel cuproptosis pattern and tumor immune microenvironment characterization in urothelial carcinoma of the bladder

FRONTIERS IN IMMUNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer

Hong Qiu et al.

Summary: Disruption of KDM6A in bladder cancer induces an epigenetic switch that inhibits urothelial differentiation and promotes cell proliferation, which is dependent on ATF3. This finding suggests that targeting this gain-of-function epigenetic switch could be a potential therapeutic strategy for bladder cancer.

CANCER RESEARCH (2023)

添加到收藏夹

Review Urology & Nephrology

The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma

Richard Cathomas et al.

Summary: The latest EAU guideline recommends platinum-based chemotherapy as the first-line standard therapy, with immunotherapy considered for PD-L1-positive patients who are ineligible for cisplatin, and maintenance immunotherapy recommended for those with nonprogressive disease.

EUROPEAN UROLOGY (2022)

添加到收藏夹

Article Oncology

Integrated proteogenomic characterization of urothelial carcinoma of the bladder

Ning Xu et al.

Summary: This study provides an integrated multi-omics analysis of Chinese UC patients, revealing the association between SND1 and CDK5 amplifications and the activation of STAT3 in tumor proliferation. It also identifies chromosome 5p gain as a high-risk factor in NMIBC patients through actin cytoskeleton modulation. Phosphoproteomic analysis identifies UC-associated activated kinases, and proteomic analysis groups UC patients into distinct prognostic and molecular signature categories. Immune subtypes of UC tumors demonstrate a complex immune landscape with the amplification of TRAF2 related to increased PD-L1 expression. Lastly, GARS is validated to promote the pentose phosphate pathway by inhibiting activities of PGK1 and PKM2 in U-II subtype.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial

Syed A. Hussain et al.

Summary: This study investigated the effect of adding nintedanib to neoadjuvant chemotherapy in muscle-invasive bladder cancer, and found that nintedanib did not improve the rate of pathological complete response.

LANCET ONCOLOGY (2022)

添加到收藏夹

Editorial Material Multidisciplinary Sciences

Copper-induced cell death Excess copper causes mitochondrial protein aggregation and triggers a distinct form of cell death

Martha A. Kahison et al.

SCIENCE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Copper induces cell death by targeting lipoylated TCA cycle proteins

Peter Tsvetkov et al.

Summary: Copper is an essential cofactor for all organisms, but excessive copper can lead to cell death. We found that copper-dependent cell death mechanism is different from known mechanisms, and it is related to mitochondrial respiration. Copper directly binds to lipoylated components of the tricarboxylic acid cycle, causing protein aggregation and loss of iron-sulfur cluster proteins, ultimately leading to cell death.

SCIENCE (2022)

添加到收藏夹

Review Immunology

Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy

Xiaochen Qi et al.

Summary: The development of cancer treatment methods is constantly changing. Precisely inducing specific cell death patterns can potentially provide a more targeted and effective approach for cancer treatment, with minimal collateral damage to normal cells.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Editorial Material Cell Biology

Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance

Maria Rosaria Ruocco et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Selective Targeting of Cancer Cells by Copper Ionophores: An Overview

Valentina Oliveri

Summary: Conventional cancer therapies face challenges due to off-target effects, leading to the need for new therapeutic agents with increased selectivity, reduced side effects, and the ability to overcome cancer cell resistance targeting cancer stem cells. Some copper ionophores show promise in inducing cuproptosis in cancer cells with greater selectivity.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

添加到收藏夹

Article Immunology

Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma

Zhen Zhang et al.

Summary: The study finds that FDX1 is downregulated in hepatocellular carcinoma (HCC), and high expression of FDX1 is associated with longer survival time. HCC patients with high cuproptosis-related risk score (CRRS) have significantly lower overall survival (OS) and are enriched in cancer-related pathways. Mutation analyses reveal high mutational frequency of tumor suppressors such as P53 and BAP1, and low mutational frequency of CTNNB1 in high-CRRS HCC patients. Additionally, high CRRS is associated with increased pro-tumor immune infiltrates and high expression of immune checkpoints. Furthermore, CRRS has a high predictive value in determining the efficiency of sorafenib and non-responsiveness to TACE in HCC patients.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Genetics & Heredity

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma

Liuqing Yang et al.

Summary: The study identified eight cuproptosis-related lncRNAs as prognostic markers in HNSC, showing potential as biomarkers for predicting the benefit of immunotherapy and drug sensitivity in HNSC.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Article Oncology

Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer

Lijiang Gu et al.

Summary: This study analyzed the role of RNA-binding proteins (RBPs) in bladder cancer (BC) and identified six RBPs that may serve as predictors of BC. By analyzing clinical information and RNA sequencing data, RBPs associated with patient survival were identified. The study also found that the expression of four RBPs was significantly upregulated in BC tissues and cell lines. A prognostic model based on these six RBPs was developed and functionally validated.

CANCERS (2022)

添加到收藏夹

Article Oncology

Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma

Zhong-Hao Ji et al.

Summary: This study characterized the changes in cuproptosis-related genes in KIRC patients and identified their association with prognosis, sensitivity, and tumor microenvironment. A CRG score was created to predict overall survival and was found to be strongly linked to the tumor microenvironment (TME).

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts

Yuchen Wang et al.

Summary: The discovery of immune checkpoint inhibitors is considered a significant breakthrough in tumor therapy, but severe side effects and ineffective treatment outcomes still exist. In addition to known molecules like PD-1/PD-L1 and CTLA-4, novel immune checkpoint molecules such as VISTA and CD39 are being widely investigated for potential clinical benefits.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Connecting copper and cancer: from transition metal signalling to metalloplasia

Eva J. Ge et al.

Summary: Copper is a essential nutrient with both beneficial and toxic properties to cells. Recent progress in transition metal signaling has led to new connections between researchers from different disciplines, with potential for translating basic research into clinical therapies for diseases. The relationship between copper and cancer is particularly important, with opportunities for leveraging disease vulnerabilities through copper-dependent signaling pathways.

NATURE REVIEWS CANCER (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Downregulation of PPAR alpha mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells

Jingkui Wu et al.

Summary: IgA nephropathy (IgAN) is the most common primary glomerulonephritis and a major cause of end-stage renal disease. The downregulation of PPAR alpha pathway affects FABP1 and GPX4 levels, leading to ferroptosis in human mesangial cells (HMCs) and contributing to the pathogenesis of IgAN.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Copper metabolism as a unique vulnerability in cancer

Vinit C. Shanbhag et al.

Summary: Over the past 25 years, significant progress has been made in identifying and characterizing proteins that regulate the uptake, intracellular trafficking and export of copper. While copper is essential for growth and development in humans and other mammals, it is also a limiting nutrient for cancer cell growth and proliferation. Oral copper chelators have been shown to have anti-neoplastic and anti-metastatic effects in animals and humans.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)

添加到收藏夹

Review Oncology

TGFβ biology in cancer progression and immunotherapy

Rik Derynck et al.

Summary: TGF beta signaling plays a key role in cancer progression by promoting cancer cell invasion, dissemination, stem cell properties, therapeutic resistance, and the generation of an immunosuppressive environment. Inhibiting TGF beta signaling is considered a crucial avenue to enhance the efficacy of cancer immunotherapies. Understanding and targeting TGF beta signaling mechanisms in tumors and their microenvironment may provide valuable insights for cancer treatment.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer

Ramon Gonzalez Manzano et al.

Summary: The co-alterations of RB1 and TP53 are strongly associated with genomic biomarkers of response to ICIs in MIBCs, indicating higher response rates and better prognosis for these tumor samples.

BMC CANCER (2021)

添加到收藏夹

Article Immunology

Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma

Hao Yuan et al.

Summary: Through analysis of clinical information and genetic transcriptome data of PDAC patients, a m5C-related lncRNA prognostic risk model was established and its relationship with PDAC immune microenvironment was studied. The risk model showed predictive ability and could potentially serve as a therapeutic target for PDAC patients.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Engineering, Biomedical

Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells

Gang Xue et al.

Summary: Targeting tumor cells can promote resistance to immune checkpoint blockade therapy, but this resistance can be overcome by depleting tumor cells and immunosuppressive cells simultaneously using a monoclonal antibody binding CD73 enzyme. This approach prevents tumors from acquiring resistance to immune checkpoint blockade and leads to the eradication of advanced tumors.

NATURE BIOMEDICAL ENGINEERING (2021)

添加到收藏夹

Article Oncology

Phosphorylation of the androgen receptor at Ser81 is co-sustained by CDK1 and CDK9 and leads to AR-mediated transactivation in prostate cancer

XinTao Gao et al.

Summary: The study highlights the significance of pS81 in CRPC, with its nuclear localization correlated with AR transactivation. ChIP analysis and ChIP-Seq demonstrated the enrichment of pS81 on AR-activated promoters.

MOLECULAR ONCOLOGY (2021)

添加到收藏夹

Article Cell Biology

Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating increment NP63 by sponging miR-762

Tianyao Liu et al.

CELL DEATH & DISEASE (2020)

添加到收藏夹

Review Medical Laboratory Technology

Long non-coding RNA in bladder cancer

Yuepeng Cao et al.

CLINICA CHIMICA ACTA (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cysteine depletion induces pancreatic tumor ferroptosis in mice

Michael A. Badgley et al.

SCIENCE (2020)

添加到收藏夹

Article Oncology

Dysregulation of Redox Status in Urinary Bladder Cancer Patients

Edyta Reszka et al.

CANCERS (2020)

添加到收藏夹

Article Oncology

Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma

Lei Lyu et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

TGF-β suppresses type 2 immunity to cancer

Ming Liu et al.

NATURE (2020)

添加到收藏夹

Review Oncology

Efficacy of intravesical therapies on the prevention of recurrence and progression of non-muscle-invasive bladder cancer: A systematic review and network meta-analysis

Jun-Lin Lu et al.

CANCER MEDICINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Bladder Cancer: A Review

Andrew T. Lenis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Review Oncology

The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy

Pierre Lelievre et al.

CANCERS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

The updated landscape of tumor microenvironment and drug repurposing

Ming-Zhu Jin et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Review Cell Biology

The molecular machinery of regulated cell death

Daolin Tang et al.

CELL RESEARCH (2019)

添加到收藏夹

Review Oncology

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

T. A. Chan et al.

ANNALS OF ONCOLOGY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

Lorenzo Galluzzi et al.

CELL DEATH AND DIFFERENTIATION (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang et al.

NATURE MEDICINE (2018)

添加到收藏夹

Review Genetics & Heredity

Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine

Jake R. Conway et al.

GENOME MEDICINE (2018)

添加到收藏夹

Review Multidisciplinary Sciences

Elements of cancer immunity and the cancer-immune set point

Daniel S. Chen et al.

NATURE (2017)

添加到收藏夹

Article Urology & Nephrology

Landmarks in the treatment of muscle-invasive bladder cancer

Niyati Lobo et al.

NATURE REVIEWS UROLOGY (2017)

添加到收藏夹

Review Oncology

A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab

Petros Fessas et al.

SEMINARS IN ONCOLOGY (2017)

添加到收藏夹

Article Cell Biology

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Pornpimol Charoentong et al.

CELL REPORTS (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson et al.

CELL (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Serum Copper and Zinc Levels Among Iranian Colorectal Cancer Patients

Zahra Khoshdel et al.

BIOLOGICAL TRACE ELEMENT RESEARCH (2016)

添加到收藏夹

Article Multidisciplinary Sciences

The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression

Lena Seifert et al.

NATURE (2016)

添加到收藏夹

Correction Multidisciplinary Sciences

Systematic pan-cancer analysis of tumour purity (vol 6, 8971, 2015)

Dvir Aran et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹

Review Medicine, General & Internal

Necroptosis

Andreas Linkermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Oncology

Cancer statistics, 2013

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

CELL (2011)

添加到收藏夹

Article Medical Laboratory Technology

Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine

S Kageyama et al.

CLINICAL CHEMISTRY (2004)

添加到收藏夹

Review Urology & Nephrology

Contemporary management of stage T1 transitional cell carcinoma of the bladder

MS Soloway et al.

JOURNAL OF UROLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.